Synthesis and biological evaluation of indolyl bisphosphonates as anti-bone resorptive and anti-leishmanial agents

• Published in: Bioorganic & medicinal chemistry 2008-09, Vol.16 (18), p.8482-8491
• Main Authors: Singh, Uma Sharan, Shankar, Ravi, Kumar, Avinash, Trivedi, Ritu, Chattopadhyay, Naibedya, Shakya, Nishi, Palne, Shraddha, Gupta, Suman, Hajela, K.
• Format: Article
• Language: English
• Subjects: Alendronate - pharmacology; Animals; Anti-bone resorptive; Anti-leishmanial activity; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antiparasitic agents; Apoptosis; Apoptosis - drug effects; Biological and medical sciences; Bone Density Conservation Agents - chemical synthesis; Bone Density Conservation Agents - pharmacology; Bone Resorption - metabolism; Bone Resorption - pathology; Bones, joints and connective tissue. Antiinflammatory agents; Cell Proliferation - drug effects; Cells, Cultured; Diphosphonates - chemical synthesis; Diphosphonates - pharmacology; Indoles - chemical synthesis; Indoles - pharmacology; Indolyl bisphosphonates; Leishmania; Leishmania - drug effects; Leishmania - metabolism; Medical sciences; Mice; Osteoclasts - metabolism; Osteoclasts - pathology; Pharmacology. Drug treatments; Structure-Activity Relationship
• ISSN: 0968-0896; 1464-3391
• DOI: 10.1016/j.bmc.2008.08.024

A series of indole conjugated bisphosphonate derivatives have been synthesized and evaluated for their in vitro anti-bone resorptive activity using bone marrow osteoclast culture. Two bisphosphonates 23 and 24 significantly inhibited osteoclastogenesis, 23 showed inhibition at 10 and 100 pM which was lower than the concentration of standard drug alendronate, and 24 inhibited osteoclastogenesis at 100 nM which was comparable to alendronate. Two other compounds 13 and 14 also showed inhibition comparable to alendronate, but were cytotoxic in the osteoblast cells. The two active bisphosphonates 23 and 24 induced significant osteoclast apoptosis at concentrations 100 nM for compound 24 and at 10 pM for compound 23 compared to alendronate. In vivo effect of active bisphosphonates 23 and 24 resulted in osteoclastogenesis of bone marrow cells (BMCs) to almost 40–50% ( 23 showing 8.4% decrease and 24 showing 9.0%) compared to 16.5% of the ovariectomized group. Further, screening of anti-leishmanial activity, four compounds 24– 25 and 27– 28 showed more than 80% inhibition against both the promastigote and amastigote stages of the Leishmania parasite.